MannKind Corp (MNKD): Operating Income
$38.80M
Year ended 2025-12-31
$9.19M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $38.80M | -46.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $72.59M | +736.4% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $8.68M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$64.11M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$47.02M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$47.91M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$44.60M | n/m | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | -$76.59M | n/m | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | -$108.19M | n/m | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | $67.26M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$344.65M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$179.63M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$169.40M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$146.96M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | -$140.54M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$152.50M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$209.78M | n/a | 2012-03-15, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| MannKind Corp (MNKD) | 2025-12-31 | $38.80M | -46.5% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$12.23M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$490.13M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $150.14M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$40.98M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$32.66M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $98.50M | +5.8% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $163.75M | -1.9% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $24.90M | n/m |
Compare MNKD, ARQT, SVA, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗